Sagility Limited delivered an exceptional performance for the fiscal year ended March 31, 2026, achieving 29.1% year-on-year revenue growth to reach ₹71,929 million. Driven by strong demand in healthcare payer operations and successful execution, the company reported a robust adjusted EBITDA margin of 25.3%. Despite industry cost pressures, Sagility continues to scale through tech-led transformation and strategic acquisitions, positioning itself for continued double-digit growth in the coming year.
Financial Performance Overview
For the full fiscal year 2026, Sagility reported revenue of ₹71,929 million ($814 million), marking a 29.1% increase over the previous year. Profitability remained strong, with adjusted EBITDA reaching ₹18,200 million ($206 million), representing a 25.3% margin. The company’s adjusted profit after tax (PAT) rose by 39.5% to ₹11,306 million, showcasing operational efficiency and disciplined financial management.
Fourth Quarter Highlights
The final quarter (ended March 31, 2026) saw revenue of ₹20,243 million ($222.1 million), a 29.1% growth in rupee terms. Adjusted EBITDA for the quarter stood at ₹5,036 million with a 24.9% margin. Commercial momentum remained robust, with the company signing $30.7 million in potential steady-state annual contract value (ACV) across 18 existing clients and two new client additions.
Strategic Growth and Market Positioning
Sagility’s growth strategy centers on expanding its footprint in the mid and small-market segments, having added 17 new clients during FY26. The company successfully reduced its top-three client concentration to below 60%. By leveraging its Synchrony suite of AI-led solutions, the company is addressing healthcare industry demands for cost takeout and improved member outcomes. The company’s management remains committed to debt reduction, targeting a complete repayment of current debt by the end of FY27.
Future Outlook
Looking ahead to FY27, Sagility projects low double-digit organic revenue growth in constant currency terms. The company anticipates adjusted EBITDA margins to hold between 24% and 25%, with a potential to reach the upper end of this guidance if foreign exchange rates remain favorable. The focus remains on driving transformation through technology, deep domain expertise, and strategic partnerships, while continuing to explore both organic and inorganic growth opportunities.
Source: BSE
